New Ladder Helps Guide Choice of Non-steroidal Treatments in AD
The Dermatology Digest
APRIL 7, 2024
A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Nonsteroidal treatment options for AD have rapidly expanded in recent years with the development of phosphodiesterase-4 inhibitors, biologics, and Janus kinase (JAK) inhibitors. Although topical corticosteroids are still considered the first line in AD, adverse effects can occur especially with prolonged usage.
Let's personalize your content